Published Date: June 2024
Cetirizine hydrochloride market is driven by increasing number of allergic conditions such as allergic rhinitis, allergic conjunctivitis, eczema, runny nose, sneezing, hives, and itching. Moreover, utilization of cetirizine hydrochloride in the treatment of angioedema and urticarial has upsurge the target market growth.Cetirizine Hydrochloride Market was valued at US$ 6.3 billion in 2024 and is projected to grow at a CAGR of 2.6% to reach US$ 8.0 billion by 2034.
The report "Cetirizine Hydrochloride Market, By Types (Capsule, Tablet and Solution), By Application (Clinic, Hospital, and Drug Store), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034"
Key Highlights:
- In August, 2019, Sun Pharmaceutical Industries Ltd. collaborated with China Medical System Holdings (CMS) to develop and commercialize generic drugs in mainland China.
Key Market Insights from the report:
Cetirizine Hydrochloride Market was valued at US$ 6.3 billion in 2024 and is projected to grow at a CAGR of 2.6% to reach US$ 8.0 billion by 2034. The market report has been segmented on the basis of types, application, and region.
- By types, the cetirizine hydrochloride market is segmented into capsule, tablet and solution.
- By end-use, the cetirizine hydrochloride market is categorized into clinic, hospital, and drug store.
- By region, North America cetirizine hydrochloride market is expected to be the dominating target market during the forecast period owing to increasing number of prevalence of hay fever as well as allergic conjunctivitis. United States has driven the target market growth in North America. Also, rising number of allergic rhinitis has majorly augmented the target market in the region. Apart from this, increased number of children with eczema has played a vital role is boosting the target market growth in North America.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on " Cetirizine Hydrochloride Market, By Types (Capsule, Tablet and Solution), By Application (Clinic, Hospital, and Drug Store), and by Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)- forecast till 3034"
The prominent player operating in the cetirizine hydrochloride market includes UCB Pharma SA, Pfizer Ltd., J & J Industries, Inc., Mylan Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Huapont Pharm. Co., Ltd., Hunan Jiudian Pharmaceutical. CO., LTD., Sun Pharmaceutical Industries Ltd., and Lunan Pharmaceutical Co., Ltd.
To know more
Contact Us:
Sales
Prophecy Market Insights
U.S: 1 860 531 2574
RoW: 91 7775049802
Email- sales@prophecymarketinsights.com
Website- www.prophecymarketinsights.com
Blog- www.prophecyjournals.com
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Custmoized Your ReportWe help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request for Discount
